logo
Plus   Neg
Share
Email

Paladin Labs Acquires Allon Therapeutics Inc.

Paladin Labs Inc. (PLB.TO), and Allon Therapeutics Inc. (NPC.TO) announced that in accordance with the Order for Reorganization in Allon's proposal proceedings under the Bankruptcy and Insolvency Act and under the Canada Business Corporations Act which have been previously announced, Paladin has become the sole shareholder of Allon.

The company said that immediately prior to Paladin becoming the sole shareholder of Allon, all existing issued and outstanding shares and other securities of Allon were, pursuant to the Court Order, cancelled without payment or other consideration.

One of the other consequences of Paladin becoming the sole shareholder of Allon is that Allon will cease being a reporting issuer in Canada, the company noted.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Lowe's Companies, Inc. (LOW) reported first-quarter net earnings of $988 million or $1.19 per share compared to $602 million or $0.70 per share, a year ago. On average, 25 analysts polled by Thomson Reuters expected the company to report profit per share of $1.27 for the quarter. Analysts' estimates... Tesla Inc.'s (TSLA) mass-market Model 3 sedan, which will be available in two new versions with dual motors and all-wheel drive in July, has failed to earn a recommendation from Consumer Reports. Department store chain Kohl's Corp. reported financial results for the first quarter that beat analysts' estimates. Meanwhile, off-price retailer TJX Companies, Inc. reported adjusted earnings for the first quarter that missed analysts' expectations, even as its revenues beat estimates. Both the companies raised their earnings outlook for the full year.
Follow RTT